SCHEMBL16092706

SCHEMBL16092706

BC(=O)/C=C/[C@H]1CCC(=O)N1C

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 13/20 0.35
▸ PTGER2 P43116 10/20 0.35
▸ PTGER3 P43115 4/20 0.32
▸ P2RX7 Q99572 7/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18948464 0.79 PTGER4 (0.31) PTGER4PTGER2
SCHEMBL16088695 0.75 PTGER4 (0.38) PTGER4PTGER2PTGER3
SCHEMBL16092649 0.75 PTGER4 (0.38) PTGER4PTGER2PTGER3
SCHEMBL16088563 0.75 PTGER4 (0.38) PTGER4PTGER2PTGER3
SCHEMBL20077485 0.71 — —
SCHEMBL16088784 0.71 — —
SCHEMBL15677667 0.71 — —
SCHEMBL7280779 0.70 — —
SCHEMBL14172559 0.69 PTGER4 (0.36) PTGER4PTGER2PTGER3
SCHEMBL18133252 0.69 PTGER4 (0.35) PTGER4PTGER2PTGER3P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2989098-B1 LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS CAYMAN CHEMICAL CO INC (US) 2017-05-10 — — EP disclosed
WO-2014144610-A1 LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS CAYMAN CHEMICAL COMPANY, INC. (US) 2014-09-18 — — WO disclosed
Send feedback